Eli Lilly & Co. (LLY)
905.03
-17.47
(-1.89%)
USD |
NYSE |
Apr 15, 16:00
908.75
+3.72
(+0.41%)
Pre-Market: 04:34
Eli Lilly Research and Development Expense (Quarterly) : 3.802B for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 1.481B |
| Viking Therapeutics, Inc. | 153.46M |
| Apellis Pharmaceuticals, Inc. | 74.23M |
| Arcellx, Inc. | 34.10M |
| Moderna, Inc. | 708.00M |